Instrument Inactif

Cours Cascadian Therapeutics Inc (USA)

Actions

Durée

Période

Style

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	04/01/18
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	02/01/18
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	13/12/17
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	07/12/17
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	08/11/17

Secteur

	Varia. 1 janv.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-0,49 %	103 Md
REGENERON PHARMACEUTICALS, INC.	+3,31 %	96,73 Md
ARGENX SE	+1,66 %	21,31 Md
BIONTECH SE	-16,16 %	21,21 Md
GENMAB A/S	-6,82 %	18,79 Md
WUXI APPTEC CO., LTD.	-41,41 %	16,37 Md
BEIGENE, LTD.	-22,87 %	13,68 Md
NEUROCRINE BIOSCIENCES, INC.	+6,32 %	13,44 Md
SAREPTA THERAPEUTICS, INC.	+21,46 %	10,98 Md